Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster
Lancet
.
2021 Mar 6;397(10277):854-855.
doi: 10.1016/S0140-6736(21)00528-6.
Authors
Ivan F N Hung
1
,
Gregory A Poland
2
Affiliations
1
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
2
Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: poland.gregory@mayo.edu.
PMID:
33676614
PMCID:
PMC8086170
DOI:
10.1016/S0140-6736(21)00528-6
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
ChAdOx1 nCoV-19
Humans
Immunization, Secondary
SARS-CoV-2
Vaccines*
Substances
COVID-19 Vaccines
Vaccines
ChAdOx1 nCoV-19